The ABCs of Immunosuppression: A Primer for Primary Care Physicians.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 27095642.
- Also identified by DOI 10.1016/j.mcna.2016.01.003.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Immunosuppression use for prevention of allograft recognition/rejection has evolved to reflect an expanded understanding of the immune system, as well as a fine tuning of the goals of therapy. Immunosuppression in organ transplantation represents a balance between the desire to improve the health status of an individual affected by chronic conditions versus not imposing an unintended immunodeficiency leading to iatrogenic morbidity/mortality. This article discusses the selection and general dosing of immunosuppression in organ allograft recipients to allow providers to be comfortable in monitoring immunosuppressive therapy long term and the associated, expected posttransplant complications in allograft recipients.
Medical subject headings
- Graft Rejection
- Immunosuppression Therapy
- Immunosuppressive Agents
- Kidney Transplantation
- Liver Transplantation
- Primary Health Care